国浩律师（上海）事务所 关于 无锡双象超纤材料股份有限公司 2024 年年度股东会 之 法律意见书 上海市静安区山西北路 99 号苏河湾中心 MT25-28 层 邮编：200085 电话：（+86）（21）5234 1668 传真：（+86）（21）5234 1670 电子信箱：grandallsh@grandall.com.cn 网址：http://www.grandall.com.cn 2025 年 5 月 国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于无锡双象超纤材料股份有限公司 本所律师已经对公司提供的与本次股东会有关的文件、资料进行审查判断， 并据此出具法律意见。 本所律师按照律师行业公认的业务标准、道德规范和勤勉尽责精神，对公司 本次股东会的召集、召开程序、出席会议人员及召集人的资格、表决程序及表决 结果等有关事宜发表如下意见： 1 2024 年年度股东会 之法律意见书 致：无锡双象超纤材料股份有限公司 国浩律师（上海）事务所（以下简称"本所"）接受无锡双象超纤材料股份 有限公司（以下简称"公司"）的委托，指派律师出席公司 2024 年年度股东会 （以下简称"本次股东会"），并根 ...

证券代码：002395 证券简称：双象股份 公告编号：2025-020 无锡双象超纤材料股份有限公司 2024年年度股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 重要提示： 1、本次股东会召开期间没有增加、否决或变更议案的情况发生； 2、本次股东会以现场投票与网络投票相结合的方式召开； 3、本次会议第18项议案须以特别决议方式通过。 一、会议召开情况 1、会议召集人：公司董事会 2、会议时间： 现场会议召开时间为：2025 年 5 月 9 日（星期五）下午 14 点 30 分开始。网络投票时间为：2025 年 5 月 9 日，其中通过深圳证券交 易所交易系统进行网络投票的具体时间为 2025 年 5 月 9 日上午 9:15～9:25，9:30～11:30，下午 13:00～15:00；通过深圳证券交易 所互联网投票系统进行网络投票的具体时间为 2025 年 5 月 9 日 9:15 至 2025 年 5 月 9 日 15:00 的任意时间。 3、会议主持人：公司董事长顾希红先生 4、现场会议召开地点：双象大酒店七楼会议室（地址：江苏省 无锡 ...

| 高端市场份额，实现做大做强目标。谢谢！ | | --- | | 问：尊敬的领导，下午好！作为中小投资者，有以 | | 下问题：1、24 年报显示，公司业绩较同期大幅增 | | 加，是否具有持续性，今年的机遇和挑战在哪？2、 | | 公司在市值管理和舆情管理有没有推出相关的制 | | 度？今年会开展哪些相关工作？ | | 答：您好：公司 2024 年度净利润实现大幅增长， | | 其中包含了确认的拆迁补偿收益，扣除非经常性损 | | 益后的净利润为 1.075 亿，比上年同期增长 | | 138.77%。2025 年子公司重庆光学 PMMA/MS 新材料 | | 项目将加快达产步伐，子公司重庆超纤二期项目产 | | 能也将得到释放。公司已制定舆情管理等相关制 | | 度。公司将坚持高质量发展、优化公司治理结构、 | | 努力提升经营业绩，实现公司内在价值与市场价值 | | 的同步提升，更好回报广大投资者。谢谢！ | | 问：公司一直严格按照相关法律法规和公司章程规 | | 范运作，保障股东权益。请问公司在公司治理结构 | | 方面有哪些特色和优势？如何确保董事会、监事会 | | 等治理机构的有效运作，提高决 ...

双象股份（002395）公告，2025年第一季度营收为6.02亿元，同比增长41.10%；净利润为6808.49万 元，同比增长264.64%。 ...

Financial Performance - The company's revenue for Q1 2025 reached ¥602,155,352.84, representing a 41.10% increase compared to ¥426,747,982.78 in the same period last year[5] - Net profit attributable to shareholders was ¥68,084,864.21, a significant increase of 264.64% from ¥18,671,839.34 in the previous year[5] - The basic earnings per share rose to ¥0.2539, up 264.80% from ¥0.0696 in the previous year[5] - The company experienced a 256.31% increase in operating profit, reaching ¥80,498,564.10, compared to ¥22,592,068.13 in the previous year[9] - The total profit for the period was ¥80,498,564.10, reflecting a 256.31% increase from the previous year's total profit of ¥22,592,068.13[9] - Net profit for the current period was ¥68,084,864.21, representing a substantial increase of 264.5% from ¥18,671,839.34 in the previous period[22] Cash Flow - The net cash flow from operating activities improved to ¥5,076,967.00, a turnaround from a negative cash flow of ¥132,111,799.41 in the same quarter last year, marking a 103.84% increase[5] - The company's cash flow from operating activities was ¥252,575,049.54, compared to ¥206,351,973.63 in the previous period[23] - Cash received from operating activities totaled ¥269,108,173.95, compared to ¥213,047,509.93 in the previous period, reflecting a growth of approximately 26.3%[24] - Cash paid for goods and services was $206,113,905.31, a decrease from $314,084,873.31, indicating a reduction of about 34.4%[24] - Cash paid to employees increased to $30,850,053.20 from $23,463,539.58, representing an increase of approximately 31.5%[24] - Cash paid for taxes was $21,217,289.79, significantly higher than $4,173,175.14, marking an increase of about 408.5%[24] - Cash inflow from financing activities was $39,261,636.71, while cash outflow totaled $70,621,184.43, leading to a net cash flow of -$31,359,547.72[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,344,500,221.16, reflecting a 3.03% increase from ¥2,275,454,192.74 at the end of the previous year[5] - Total current assets amount to ¥1,233,129,658.36, compared to ¥1,164,305,568.02 at the beginning of the period, showing an increase of approximately 5.9%[16] - Total liabilities rose to ¥915,994,063.12, a slight increase from ¥915,374,081.27, indicating a growth of 0.7%[18] - Fixed assets decreased to ¥937,159,003.99 from ¥949,361,076.18, a decline of about 1.3%[16] Research and Development - The company reported a 30.12% increase in R&D expenses, totaling ¥22,373,856.56, compared to ¥17,195,018.36 in the same period last year[8] - Research and development expenses for the current period were ¥22,373,856.56, an increase from ¥17,195,018.36 in the prior period, reflecting a focus on innovation[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 16,348[11] - Jiangsu Shuangxiang Group Co., Ltd. holds 64.52% of the shares, totaling 173,045,285 shares, with 91,000,000 shares pledged[11] - The company has no preferred shareholders or significant changes in the top ten shareholders due to margin trading[12] - There are no related party transactions or concerted actions among the top shareholders, ensuring transparency in ownership[12] Other Financial Information - The company received demolition compensation of ¥557,470,096.00 out of a total compensation of ¥603,752,398.00 as of March 31, 2025[13] - Total operating costs amounted to ¥525,265,515.98, up 29.5% from ¥405,565,849.70 in the prior period[20] - The deferred income tax assets increased to ¥7,491,811.10 from ¥7,372,347.20, showing a growth of 1.6%[17] - The total equity attributable to the parent company increased to ¥1,428,506,158.04 from ¥1,360,080,111.47, marking a growth of 5.0%[18] - The company did not undergo an audit for the first quarter report, which was released on April 23, 2025[26]

Group 1 - The acrylic acid concept sector increased by 1.89%, ranking second in terms of sector gains, with seven stocks rising, including Bohai Chemical which hit the daily limit, and Shenyang Chemical, Benli Technology, and Akolai showing gains of 7.65%, 4.48%, and 2.50% respectively [1] - The main funds in the acrylic acid concept sector experienced a net outflow of 215 million yuan, with six stocks seeing net inflows, led by Bohai Chemical with a net inflow of 56.065 million yuan [2][3] - The net inflow ratios for Bohai Chemical, Shenyang Chemical, and Baolijia were 31.95%, 18.48%, and 5.62% respectively, indicating strong interest from main funds [3] Group 2 - The top gainers in the acrylic acid concept included Bohai Chemical, Shenyang Chemical, and Baolijia, while the top decliners were Tianlong Group, Wanhua Chemical, and Rike Chemical, with declines of 2.68%, 1.09%, and 1.01% respectively [1][4] - The trading volume and turnover rates for the leading stocks in the acrylic acid concept were notable, with Bohai Chemical showing a turnover rate of 5.07% and Shenyang Chemical at 7.38% [3][4] - The overall market sentiment in the acrylic acid sector appears positive despite some individual stock declines, reflecting a mixed but generally upward trend in the sector [1][2]

2025年04月23日，双象股份2024年度业绩网上说明会在全景网顺利举行。出席本次业绩说明会的人员有 总经理刘连伟、独立董事蔡桂如、副总经理兼董事会秘书沈铭、财务总监金梅。 根据全景数据后台统计，在今天的交流过程中，来自全国多个省、市地区的投资者共向上市公司提问5 个，公司嘉宾共回答问题5个，答复率100.00%，充分实现了上市公司与投资者的良好互动。 以下为业绩说明会问答实录： 1、问：领导，您好！我来自四川大决策请问：公司在光学级 PMMA 材料方面有着怎样具体的规划？ 【征集问题】 回答：您好：公司将深耕光学级PMMA材料，增加改性、染色等高端产品占比，进一步扩大高端客 户、高端市场份额，实现做大做强目标。谢谢！ 2、问：2024年公司净利润增幅显著高于营收增幅，这种盈利能力的提升是否具有可持续性？未来公司 如何继续保持这种良好的盈利态势？【征集问题】 回答：您好：公司2024年度净利润实现大幅增长，其中扣除非经常性损益后的净利润为1.075亿，增长 138.77%。公司将加快重庆光学PMMA/MS新材料项目达产步伐和重庆超纤二期项目产能释放，力争 2025年营收和效益的增长。谢谢！ 3、问：公司一直 ...

Core Insights - As of April 21, 2024, 2,246 companies have released their annual reports, with 1,197 reporting a year-on-year increase in net profit, while 1,049 reported a decline [1] - A total of 1,341 companies saw an increase in operating revenue, whereas 904 experienced a decrease [1] - Companies that reported simultaneous growth in both net profit and operating revenue include 940 firms, while 648 companies saw declines in both metrics [1] - Notably, 234 companies achieved a net profit growth rate exceeding 100%, with Zhengdan Co., Ltd. leading at an impressive 11,949.39% increase [1] Company Performance Summary - Zhengdan Co., Ltd. (300641) reported earnings per share of 2.35 yuan, with a net profit of 1,189.89 million yuan, reflecting a year-on-year increase of 11,949.39%, and operating revenue of 348.02 million yuan, up 126.31% [1] - Guangxi Energy (600310) reported earnings per share of 0.043 yuan, with a net profit of 62.99 million yuan, a significant increase of 3,704.04%, but a decline in operating revenue by 76.48% to 393.16 million yuan [1] - Siwei (688213) achieved earnings per share of 0.98 yuan, with a net profit of 39.27 million yuan, marking a 2,662.76% increase, and operating revenue of 596.81 million yuan, up 108.87% [1] - Other notable performers include Andis (600299) with a net profit of 120.43 million yuan (up 2,208.66%) and operating revenue of 1,553.43 million yuan (up 17.83%) [1] - Companies like Huabei Pharmaceutical (600812) and Jiangsu Suo (600746) also reported significant changes in their financial metrics, with varying trends in net profit and operating revenue [1][2]

Group 1 - Company Instech reported a net profit of 177 million yuan for 2024, a year-on-year increase of 28.15%, with a proposed cash dividend of 1.20 yuan per 10 shares [1] - Instech achieved an operating revenue of 1.185 billion yuan in 2024, representing a year-on-year growth of 24.45% [1] - The company specializes in the research, production, and sales of rare earth permanent magnet materials and applications [2] Group 2 - Company Junda reported a net loss of 106 million yuan for Q1 2025, transitioning from profit to loss, with a year-on-year revenue decline of 49.52% [3] - Junda's operating revenue for Q1 2025 was 1.875 billion yuan [3] - The company focuses on the research, production, and sales of photovoltaic cell products [4] Group 3 - Company Annada reported a net loss of 10.26 million yuan for Q1 2025, with a year-on-year revenue increase of 1.44% [5] - Annada's operating revenue for Q1 2025 was 473 million yuan [5] - The company specializes in titanium dioxide and iron phosphate products [6] Group 4 - Company Jiuzhou Pharmaceutical reported a net profit of 250 million yuan for Q1 2025, a year-on-year increase of 5.68% [7] - Jiuzhou's operating revenue for Q1 2025 was 1.49 billion yuan, reflecting a year-on-year growth of 0.98% [7] - The company provides custom research and production services for pharmaceutical companies and research institutions [8] Group 5 - Company Yitong Century won a 1.48 billion yuan contract for a 5G comprehensive maintenance project with Guangdong Unicom [9] - The project will enhance the company's business volume and expansion in Guangdong [9] - Yitong Century specializes in communication network technology services and solutions [10] Group 6 - Company Rijiu Optoelectronics reported a net profit of 67.47 million yuan for 2024, a year-on-year increase of 506.9%, with a proposed cash dividend of 2.00 yuan per 10 shares [10] - Rijiu's operating revenue for 2024 was 583 million yuan, representing a year-on-year growth of 22% [10] - The company focuses on the research, production, and sales of touch display application materials [11] Group 7 - Company Ruotong reported a net profit of 95.98 million yuan for 2024, a year-on-year increase of 0.91%, with a proposed cash dividend of 2.00 yuan per 10 shares [12] - Ruotong's operating revenue for 2024 was 408 million yuan, reflecting a year-on-year growth of 7.54% [12] - The company specializes in drilling and completion equipment for oil and gas [13] Group 8 - Company Shuangxiang reported a net profit of 472 million yuan for 2024, a year-on-year increase of 754.84%, with a proposed cash dividend of 1.50 yuan per 10 shares [14] - Shuangxiang's operating revenue for 2024 was 2.29 billion yuan, representing a year-on-year growth of 51.55% [14] - The company focuses on synthetic leather and optical-grade PMMA products [15] Group 9 - Company Xinfang Pharmaceutical reported a net profit of 101 million yuan for 2024, a year-on-year decrease of 64.70%, with a proposed cash dividend of 0.30 yuan per 10 shares [16] - Xinfang's operating revenue for 2024 was 6.032 billion yuan, reflecting a year-on-year decline of 6.63% [16] - The company is involved in medical services, pharmaceutical distribution, and manufacturing [17] Group 10 - Company Dongxing Medical reported a net profit of 97.42 million yuan for 2024, a year-on-year increase of 0.21%, with a proposed cash dividend of 6.00 yuan per 10 shares [18] - Dongxing's operating revenue for 2024 was 435 million yuan, reflecting a year-on-year growth of 0.40% [18] - The company specializes in surgical medical devices [19] Group 11 - Company Wuzhou Special Paper reported a net profit of 64.68 million yuan for Q1 2025, a year-on-year decrease of 51.56%, with an operating revenue of 1.989 billion yuan [20] - Wuzhou's operating revenue for Q1 2025 increased by 15.21% [20] - The company focuses on the research, production, and sales of mechanism paper and pulp [21] Group 12 - Company Jinrui Mining expects a net profit of 15.28 million yuan for Q1 2025, a year-on-year increase of 617.40% [22] - The company specializes in the production and sales of strontium salt products [23] Group 13 - Company Youyan New Materials expects a net profit of 60 million to 75 million yuan for Q1 2025, a year-on-year increase of 13076% to 16370% [24] - The company focuses on electronic films, precious metal materials, and rare earth materials [25] Group 14 - Company Guoli expects a net profit of 11 million to 13 million yuan for Q1 2025, a year-on-year increase of 164.38% to 212.45% [26] - The company specializes in urban infrastructure design, construction, and investment [27] Group 15 - Company Shenzhen Airport reported a passenger throughput of 5.5422 million in March, a year-on-year increase of 8.70% [28] - The airport's cargo throughput was 171,900 tons, reflecting a year-on-year growth of 14.51% [28] - The company is involved in aviation and related non-aviation businesses [29] Group 16 - Company Shenghui Integration reported an order balance of 2.117 billion yuan as of March 31, 2025, a year-on-year increase of 11.89% [30] - The company provides cleanroom engineering and electromechanical engineering services [31] Group 17 - Company Chengyi Pharmaceutical received a drug registration certificate for Mercaptopurine tablets [32] - The drug is applicable for various diseases including choriocarcinoma and acute lymphoblastic leukemia [32] Group 18 - Company Enhua Pharmaceutical initiated Phase I clinical trials for NH280105 capsules, targeting Alzheimer's disease [33] - The trial aims to assess the safety and pharmacokinetics of the drug [33] Group 19 - Company Lingang Steel proposed a share buyback of 50 million to 100 million yuan [34] - The company specializes in the production and development of metallurgical products [35] Group 20 - Company Fujia plans to repurchase shares worth 15 million to 30 million yuan [36] - The company focuses on smart cleaning appliances and key components [37] Group 21 - Company Mould Technology received a project designation letter for exterior parts from a luxury car client, with an estimated total sales of 2.07 billion yuan [38] - The project is expected to start mass production in April 2027 [38] Group 22 - Company Longxin General expects a net profit of 4.55 billion to 5.30 billion yuan for Q1 2025, a year-on-year increase of 76.65% to 105.77% [39] - The company specializes in motorcycles, engines, and general machinery products [40] Group 23 - Company Dongfang Securities reported a net profit of 1.436 billion yuan for Q1 2025, a year-on-year increase of 62.08% [41] - The company focuses on investment management and securities trading [42] Group 24 - Company Yalian Machinery plans to use up to 800 million yuan of idle funds for low-risk financial products [43] - The company specializes in the production of engineered wood production lines and equipment [44] Group 25 - Company Guanghua Technology reported a net loss of 205 million yuan for 2024, with total revenue of 2.589 billion yuan [45] - The company focuses on PCB chemicals and lithium battery materials [46] Group 26 - Company Boya Biotechnology plans to publicly transfer 80% of its subsidiary's equity for 213 million yuan [47] - The transaction aims to optimize resource allocation focusing on blood products [48] Group 27 - Company Darui Electronics plans to repurchase shares worth 30 million to 50 million yuan [49] - The company specializes in customized components and automation equipment [50] Group 28 - Company Hongying Intelligent plans to repurchase shares worth 30 million to 40 million yuan [51] - The company focuses on smart control products and assemblies [52] Group 29 - Company Guangku Technology announced a change in the upper shareholding structure of its controlling shareholder [53] - The operational activities of the company will not be materially affected [54] Group 30 - Company Dingjie Smart's application for convertible bond issuance has been accepted by the Shenzhen Stock Exchange [55] - The company provides digital and intelligent solutions for various industries [56]

1、公司监事会于 2024 年 4 月 13 日召开了第七届监事会第九次 会议，会议审议通过了： 无锡双象超纤材料股份有限公司 2024 年度监事会工作报告 2024年度，公司监事会全体成员按照《公司法》、《证券法》、 《公司章程》、《公司监事会议事规则》等相关规定和要求，本着恪 尽职守、勤勉尽责的工作态度，依法独立行使职权，对公司生产经营、 重大事项、财务状况以及董事、高级管理人员履职情况进行了监督， 较好地保障了股东权益、公司利益和员工的合法权益，促进了公司规 范运作。现将监事会在本年度的主要工作情况报告如下： 一、2024年度监事会会议情况 2024年度，公司监事会共召开五次会议，会议情况及决议内容如 下： （1）审议《关于<公司 2023 年度监事会工作报告>的议案》 案》 5、公司监事会于 2024 年 11 月 27 日召开了第七届监事会第十三 次会议，会议审议通过了《关于转让全资子公司股权暨关联交易的议 案》。 二、监事会对有关事项的意见 1、公司依法运作情况 2024年度，公司监事会严格按照《公司法》、《公司章程》、《监 事会议事规则》等有关规定，认真履行职责，列席了公司召开的所有 股东大会和 ...